Orion Corporation B - stock earnings
ORNBV.HE Upcoming estimated earnings
| Date | Low Revenue | Average Revenue | High Revenue |
|---|---|---|---|
| April 25, 2024 AfterMarket | 302.0 million | 307.4 million | 310.7 million |
ORNBV.HE Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | 75.2 million EUR | 321.1 million EUR |
| 2023Q3 | 61.3 million EUR | 301.1 million EUR |
| 2023Q2 | 36.4 million EUR | 289.5 million EUR |
| 2023Q1 | 43.8 million EUR | 278.0 million EUR |
| 2022Q4 | 31.6 million EUR | 294.6 million EUR |
| 2022Q3 | 194.5 million EUR | 491.9 million EUR |
| 2022Q2 | 66.1 million EUR | 283.7 million EUR |
| 2022Q1 | 57.3 million EUR | 270.6 million EUR |
| 2021Q4 | 32.8 million EUR | 276.5 million EUR |
| 2021Q3 | 45.4 million EUR | 240.9 million EUR |
| 2021Q2 | 56.0 million EUR | 254.9 million EUR |
| 2021Q1 | 59.6 million EUR | 268.6 million EUR |
| 2020Q4 | 25.5 million EUR | 255.4 million EUR |
| 2020Q3 | 51.4 million EUR | 250.3 million EUR |
| 2020Q2 | 75.6 million EUR | 292.5 million EUR |
| 2020Q1 | 67.4 million EUR | 279.9 million EUR |
| 2019Q4 | 45.2 million EUR | 274.5 million EUR |
| 2019Q3 | 71.6 million EUR | 283.7 million EUR |
| 2019Q2 | 40.8 million EUR | 251.7 million EUR |
| 2019Q1 | 42.8 million EUR | 241.0 million EUR |
| 2018Q4 | 53.1 million EUR | 262.4 million EUR |
| 2018Q3 | 34.3 million EUR | 221.8 million EUR |
| 2018Q2 | 185.7 million EUR | 246.1 million EUR |
| 2018Q1 | 57.1 million EUR | 247.1 million EUR |
| 2017Q4 | 55.2 million EUR | 280.4 million EUR |
| 2017Q3 | 44.1 million EUR | 252.7 million EUR |
| 2017Q2 | 56.5 million EUR | 272.4 million EUR |
| 2017Q1 | 70.3 million EUR | 279.2 million EUR |
| 2016Q4 | 47.6 million EUR | 279.9 million EUR |
| 2016Q3 | 72.5 million EUR | 258.6 million EUR |
| 2016Q2 | 65.7 million EUR | 273.1 million EUR |
| 2016Q1 | 63.3 million EUR | 262.0 million EUR |
| 2015Q4 | 39.4 million EUR | 261.6 million EUR |
| 2015Q3 | 45.3 million EUR | 239.1 million EUR |
| 2015Q2 | 57.7 million EUR | 255.0 million EUR |
| 2015Q1 | 65.7 million EUR | 259.9 million EUR |
| 2014Q4 | 40.8 million EUR | 255.3 million EUR |
| 2014Q3 | 49.8 million EUR | 238.4 million EUR |
| 2014Q2 | 68.0 million EUR | 276.6 million EUR |
| 2014Q1 | 52.6 million EUR | 245.0 million EUR |
| 2013Q4 | 55.7 million EUR | 272.6 million EUR |
| 2013Q3 | 49.1 million EUR | 236.9 million EUR |
| 2013Q2 | 45.9 million EUR | 248.1 million EUR |
| 2013Q1 | 55.6 million EUR | 249.3 million EUR |
| 2012Q4 | 42.9 million EUR | 254.3 million EUR |
| 2012Q3 | 57.1 million EUR | 245.8 million EUR |
| 2012Q2 | 49.2 million EUR | 232.8 million EUR |
| 2012Q1 | 59.6 million EUR | 247.4 million EUR |
| 2011Q4 | 45.2 million EUR | 236.1 million EUR |
| 2011Q3 | 47.8 million EUR | 210.7 million EUR |
| 2011Q2 | 48.0 million EUR | 227.0 million EUR |
| 2011Q1 | 68.5 million EUR | 244.1 million EUR |
| 2010Q4 | 36.7 million EUR | 214.9 million EUR |
| 2010Q3 | 51.6 million EUR | 213.2 million EUR |
| 2010Q2 | 44.0 million EUR | 207.4 million EUR |
| 2010Q1 | 52.4 million EUR | 214.5 million EUR |
| 2009Q4 | 33.0 million EUR | 193.3 million EUR |
| 2009Q3 | 40.3 million EUR | 191.8 million EUR |
| 2009Q2 | 36.2 million EUR | 196.4 million EUR |
| 2009Q1 | 41.9 million EUR | 190.1 million EUR |
| 2008Q4 | ? EUR | 180.6 million EUR |
| 2008Q3 | ? EUR | 170.1 million EUR |
| 2008Q2 | ? EUR | 180.6 million EUR |
| 2008Q1 | ? EUR | 180.2 million EUR |
| 2007Q4 | ? EUR | 174.5 million EUR |
| 2007Q3 | ? EUR | 164.8 million EUR |
| 2007Q2 | ? EUR | 167.2 million EUR |
| 2007Q1 | ? EUR | 179.9 million EUR |
| 2006Q2 | ? EUR | 157.0 million EUR |
| 2006Q1 | ? EUR | 507.2 million EUR |
| 2005Q4 | ? EUR | 485.6 million EUR |
| 2005Q3 | ? EUR | 462.2 million EUR |
| 2005Q2 | ? EUR | 490.0 million EUR |
| 2005Q1 | ? EUR | 468.3 million EUR |
| 2004Q4 | ? EUR | 477.0 million EUR |
| 2004Q3 | ? EUR | 475.4 million EUR |
| 2004Q2 | ? EUR | 498.5 million EUR |
| 2004Q1 | ? EUR | 499.7 million EUR |
ORNBV.HE Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 216.8 million EUR | 1.2 billion EUR |
| 2022 | 349.5 million EUR | 1.3 billion EUR |
| 2021 | 193.8 million EUR | 1.0 billion EUR |
| 2020 | 219.9 million EUR | 1.1 billion EUR |
| 2019 | 200.4 million EUR | 1.1 billion EUR |
| 2018 | 330.3 million EUR | 977.4 million EUR |
| 2017 | 226.0 million EUR | 1.1 billion EUR |
| 2016 | 249.0 million EUR | 1.1 billion EUR |
| 2015 | 208.2 million EUR | 1.0 billion EUR |
| 2014 | 211.3 million EUR | 1.0 billion EUR |
| 2013 | 206.2 million EUR | 1.0 billion EUR |
| 2012 | 208.9 million EUR | 980.3 million EUR |
| 2011 | 209.5 million EUR | 917.9 million EUR |
| 2010 | 184.7 million EUR | 849.9 million EUR |
| 2009 | 151.4 million EUR | 771.5 million EUR |
| 2008 | 136.3 million EUR | 710.7 million EUR |
| 2007 | 145.4 million EUR | 683.6 million EUR |
| 2006 | 66.6 million EUR | 311.2 million EUR |
| 2005 | 131.1 million EUR | 1.9 billion EUR |
| 2004 | 90.5 million EUR | 1.9 billion EUR |
| 2003 | 65.5 million EUR | 2.3 billion EUR |
| 2002 | ? EUR | 1.6 billion EUR |
| 2001 | ? EUR | 970.8 million EUR |
| 2000 | ? EUR | 947.5 million EUR |
ORNBV.HE
Price: €32.40
52 week price:
Dividend Yield: 0.05%
5-year range yield:
Forward Dividend Yield: 2.51%
Payout Ratio: 65.32%
Payout Ratio Range:
Dividend Per Share: 0.81 EUR
Earnings Per Share: 1.54 EUR
P/E Ratio: 34.44
Exchange: HEL
Sector: Healthcare
Industry: Drug Manufacturers - General
Volume: 133356
Market Capitalization: 4.7 billion
Average Dividend Frequency: 1
Years Paying Dividends: 25
DGR3: -14.44%
DGR5: 12.02%
DGR10: 7.15%
DGR20: 30.00%